These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 2154591)

  • 21. Coronavirus transcription: a perspective.
    Sawicki SG; Sawicki DL
    Curr Top Microbiol Immunol; 2005; 287():31-55. PubMed ID: 15609508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions between coronavirus nucleocapsid protein and viral RNAs: implications for viral transcription.
    Baric RS; Nelson GW; Fleming JO; Deans RJ; Keck JG; Casteel N; Stohlman SA
    J Virol; 1988 Nov; 62(11):4280-7. PubMed ID: 2845140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterizations of coronavirus cis-acting RNA elements and the transcription step affecting its transcription efficiency.
    An S; Makino S
    Virology; 1998 Mar; 243(1):198-207. PubMed ID: 9527929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of intracellular small RNAs of mouse hepatitis virus: evidence for discontinuous transcription.
    Baric RS; Shieh CK; Stohlman SA; Lai MM
    Virology; 1987 Feb; 156(2):342-54. PubMed ID: 3027983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcription strategy of coronaviruses: fusion of non-contiguous sequences during mRNA synthesis.
    Spaan W; Delius H; Skinner MA; Armstrong J; Rottier P; Smeekens S; Siddell SG; van der Zeijst B
    Adv Exp Med Biol; 1984; 173():173-86. PubMed ID: 6331109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coronavirus subgenomic minus-strand RNAs and the potential for mRNA replicons.
    Sethna PB; Hung SL; Brian DA
    Proc Natl Acad Sci U S A; 1989 Jul; 86(14):5626-30. PubMed ID: 2546161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of coronavirus transcription: duration of primary transcription initiation activity and effects of subgenomic RNA transcription on RNA replication.
    Jeong YS; Makino S
    J Virol; 1992 Jun; 66(6):3339-46. PubMed ID: 1583719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Replication of synthetic defective interfering RNAs derived from coronavirus mouse hepatitis virus-A59.
    Luytjes W; Gerritsma H; Spaan WJ
    Virology; 1996 Feb; 216(1):174-83. PubMed ID: 8614984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of murine coronavirus RNA by hybridization with virus-specific cDNA probes.
    Weiss SR; Leibowitz JL
    J Gen Virol; 1983 Jan; 64 (Pt 1)():127-33. PubMed ID: 6185631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of leader-related small RNAs in coronavirus-infected cells: further evidence for leader-primed mechanism of transcription.
    Baric RS; Stohlman SA; Razavi MK; Lai MM
    Virus Res; 1985 Jul; 3(1):19-33. PubMed ID: 2992183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two murine coronavirus genes suffice for viral RNA synthesis.
    Kim KH; Makino S
    J Virol; 1995 Apr; 69(4):2313-21. PubMed ID: 7884877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolution and persistence mechanisms of mouse hepatitis virus.
    Chen W; Baric RS
    Adv Exp Med Biol; 1995; 380():63-71. PubMed ID: 8830548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coronaviruses use discontinuous extension for synthesis of subgenome-length negative strands.
    Sawicki SG; Sawicki DL
    Adv Exp Med Biol; 1995; 380():499-506. PubMed ID: 8830530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific binding of host cellular proteins to multiple sites within the 3' end of mouse hepatitis virus genomic RNA.
    Yu W; Leibowitz JL
    J Virol; 1995 Apr; 69(4):2016-23. PubMed ID: 7884846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of deletion of a conserved 11 nucleotide sequence on mouse hepatitis virus RNA replication.
    Repass JF; Makino S
    Adv Exp Med Biol; 1998; 440():247-52. PubMed ID: 9782288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro replication of mouse hepatitis virus strain A59.
    Compton SR; Rogers DB; Holmes KV; Fertsch D; Remenick J; McGowan JJ
    J Virol; 1987 Jun; 61(6):1814-20. PubMed ID: 3033313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Solubilization and immunoprecipitation of alphavirus replication complexes.
    Barton DJ; Sawicki SG; Sawicki DL
    J Virol; 1991 Mar; 65(3):1496-506. PubMed ID: 1847467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Replication of semliki forest virus: polyadenylate in plus-strand RNA and polyuridylate in minus-strand RNA.
    Sawicki DL; Gomatos PJ
    J Virol; 1976 Nov; 20(2):446-64. PubMed ID: 978799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetics of mouse hepatitis virus transcription: identification of cistrons which may function in positive and negative strand RNA synthesis.
    Schaad MC; Stohlman SA; Egbert J; Lum K; Fu K; Wei T; Baric RS
    Virology; 1990 Aug; 177(2):634-45. PubMed ID: 2164727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mouse hepatitis virus A59: mRNA structure and genetic localization of the sequence divergence from hepatotropic strain MHV-3.
    Lai MM; Brayton PR; Armen RC; Patton CD; Pugh C; Stohlman SA
    J Virol; 1981 Sep; 39(3):823-34. PubMed ID: 6169842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.